Evogene Operating Expenses Growth & History (EVGN)

Evogene's operating expenses was $13.8M for fiscal 2025.

View full Evogene company overview

Evogene annual operating expenses history

Evogene annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$13.8M−$8.2M−37.31%
20242024-12-31$22.0M−$1.7M−7.26%
20232023-12-31$23.7M−$4.0M−14.38%
20222022-12-31$27.7M−$3.4M−10.96%
20212021-12-31$31.1M$5.8M+23.09%
20202020-12-31$25.3M$3.7M+17.12%
20192019-12-31$21.6M$1.3M+6.41%
20182018-12-31$20.3M−$2.2M−9.78%
20172017-12-31$22.5M$493,000+2.24%
20162016-12-31$22.0M$1.2M+5.75%
20152015-12-31$20.8M

Evogene operating expenses trends

Over the last five fiscal years, Evogene's operating expenses decreased from $25.3M to $13.8M, a change of −$11.5M. The latest reported quarter, Q2 2026, shows $2.7M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Evogene source filings ↗

Community posts

It’s quiet here.

No posts about EVGN yet. Start the conversation.

Write the first post